United Therapeutics (UTHR) Reports In-Line Q4 EPS, Beats on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 595.57 -5.75 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $601.32 | 52 Week High | $164.04 | |||
| Open | $583.63 | 52 Week Low | $97.52 | |||
| Day High | $601.00 | P/E | 108.88 | |||
| Day Low | $580.00 | EPS | $5.47 | |||
| Volume | 142,464 | |||||
